Evidence map›Paper›PMID 39896504›Full record

ArticlebioRxiv : the preprint server for biology2025

SLAMF6 enables efficient attachment, synapse formation, and killing of HIV-1-infected CD4

Blandine Monel, Pedro A Lamothe, James Meyo, Anna P McLean, Raymond Quinones-Alvarado, Mélanie Laporte, Julie Boucau, Bruce D Walker, Daniel G Kavanagh, Wilfredo F Garcia-Beltran and 1 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Blandine MonelRagon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0002-6096-873X
Pedro A LamotheRagon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0001-9262-2920
James MeyoRagon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.
Anna P McLeanRagon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.
Raymond Quinones-AlvaradoRagon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0001-8471-8201
Mélanie LaporteNantes Université, Univ Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, F-44000 Nantes, France.
Julie BoucauRagon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.
Bruce D WalkerRagon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0001-6122-9245
Daniel G KavanaghRagon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.
Wilfredo F Garcia-BeltranRagon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.
Yovana PachecoRagon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0002-0722-546X

Funding

HLA restriction and TCR affinity in HIVR56AI095088 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KAVANAGH, DANIEL GARRETT · 2011 to 2011
$439k
NIAID NIH HHS R56 AI095088
6 · The paper itself

Abstract

Efficient recognition and elimination of HIV-1-infected CD4

Indexed as

Cytokine productionCytotoxic immune responseCytotoxic T lymphocytes (CTLs)HIV-1Immunological synapseSLAMF6

Identifiers

PMID39896504
PMCPMC11785116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.